GSK plc
GLAXF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001131399
No open-market purchases or sales by GSK plc insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $70.1M in total; no superinvestor holds it.
Other share classesGSK
Q1 2025 vs. Q4 2024
How the institutions holding GSK plc changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 2 | 1 | −1 |
| Shares | 3.37M | 3.08M | −283.5K (−8.4%) |
| Value | $56.8M | $58.2M | +$1.41M (+2.5%) |
New holders (0)
Institutions that held GSK plc at the end of Q1 2025 but not at the end of Q4 2024.
None.
Sold out (1)
Institutions that held GSK plc at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Vermillion & White Wealth Management Group, LLC | 6 | $101 |